Trial intelligence / Profile preview

DuoTrav vs Xalacom in Exfoliative Glaucoma

NCT00757835Phase 4Completed

Sponsor
Aristotle University of Thessaloniki
Start
May 2008
Primary completion
Mar 2009
Modality
Small Molecules
01

Overview

A Phase 4 trial of travoprost + timolol in pseudoexfoliative glaucoma (PEXG), sponsored by Aristotle University of Thessaloniki. Started May 2008; status: completed.

02

Drugs

travoprost + timolol
03

Conditions

pseudoexfoliative glaucoma (PEXG)

Beyond the preview

Go deeper on NCT00757835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00757835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call